Andreas G Moraitis Lita A Freeman Robert D Shamburek Robert Wesley Wyndham Wilson Cliona M Grant Susan Price Stephen Demosky Seth G Thacker Abdalrahman Zarzour Ronald L Hornung Frank Pucino Gyorgy Csako Cheryl Yarboro Iain B McInnes Takashi Kuroiwa Dimitrios Boumpas V Koneti Rao Gabor G Illei Alan T Remaley
10.1016/j.jacl.2014.09.014
J Clin Lipidol
2015 Jan-Feb;9(1):81-90.
alps b-cell lymphoma dyslipidemia hypertriglyceridemia il-10 intravascular large b-cell lymphoma lcat psoriasis severe hdl deficiency “disappearing hdl syndrome”
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/25670364/
Cholesterol, HDL / blood Dyslipidemias / diagnosis Interleukin-10 / blood
Cholesterol, HDL / blood Dyslipidemias / diagnosis Interleukin-10 / blood Case Reports Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Adult Arthritis, Psoriatic / drug therapy Autoimmune Lymphoproliferative Syndrome / blood Autoimmune Lymphoproliferative Syndrome / diagnosis Child Cholesterol, LDL / blood Cohort Studies Dyslipidemias / blood Enzyme-Linked Immunosorbent Assay Female Humans Infant Interleukin-10 / genetics Interleukin-10 / therapeutic use Lymphoma, B-Cell / diagnosis Lymphoma, Large B-Cell, Diffuse / diagnosis Male Middle Aged Placebo Effect Recombinant Proteins / biosynthesis Recombinant Proteins / genetics Recombinant Proteins / therapeutic use Treatment Outcome Triglycerides / blood fas Receptor / genetics Cholesterol, HDL Cholesterol, LDL FAS protein, human Recombinant Proteins Triglycerides fas Receptor Interleukin-10
PMC5513489
25670364
Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency
2015